Matthew L. Marshall litigates product liability cases primarily in the life science industry, in matters involving medical device, pharmaceutical, and dietary supplement claims.
Education
J.D., Loyola Marymount University, Los Angeles, California, 1993
University of California-Los Angeles (UCLA), Los Angeles, California, 1990
Recognitions
Named among The Best Lawyers in America® for Mass Tort Litigation/Class Actions – Defendants (2025) by Best Lawyers
Medmarc Attorney of the Year – 2022
State Bar Licenses
California
Court Admissions
U.S. Court of Appeals, 9th Circuit
U.S. District Ct., C.D. of California
U.S. District Ct, District of Colorado
U.S. District Ct., E.D. of California
U.S. District Ct., S.D. of California
Supreme Court of California
Articles and Presentations
- Co-author, “Colorado Court of Appeals Clarifies Permissibility of Substituted Service of Process Under Hague Service Convention,” July 1, 2025
- Presenter, “Medical Device v2.0: Safer but Riskier? – Litigation and Compliance Implications for Medical Device Improvements,” Medmarc Insurance Risk Management Webinar Series, June 25, 2025
- Presenter, “The Texas Two-Step: The Steps, Turns and Spins of Mitigating Mass Tort Liability Through Bankruptcy,” Medmarc 2025 Medical Device Seminar, June 13, 2025
- Co-author, “Artificial Intelligence or Innocent Ignorance? Hard Lessons Yield Best Practices,” June 10, 2025
- Co-author, “California Supreme Court holds that limitations of liability provisions are unenforceable for willful conduct under Civil Code Section 1668,” April 29, 2025
- Co-author, “Ninth Circuit expands specific jurisdiction for e-commerce platforms,” April 23, 2025
- Co-author, “Colorado Court of Appeals holds that the Felonious Killing Exception Applies to Corporations” March 21, 2025
- Author, “New FDA Draft Guidance on Medical Product Communications: What You Need to Know,” January 20, 2017
- “FDA Regulations, Medical Causation, and Treating Provider Depositions,” webcast co-presented by DRI’s Drug and Medical Device Committee and Young Lawyers Committee, December 12, 2013
- “Decision Limits Exposure for Medical Device Manufacturers,” Los Angeles Daily Journal, July 9, 2013
- “California Appellate Court Decision Favorable for Medical Device Manufacturers,” Email Alert, July 8, 2013
- “Introducing new rules for depositions, effective Jan. 1,” Los Angeles Daily Journal, December 31, 2012
- “Justices Limit Exposure of Foreign Businesses to US Litigation,” Los Angeles Daily Journal, July 7, 2011
- “Supreme Court Rules that State Failure to Warn Claims Against Generic Drug Manufacturers are Preempted,” June 27, 2011
- “The Nuts and Bolts of Product Liability Litigation,” September 2010
- “Co-Defendants in Drug & Medical Device Litigation – Powerful Allies/Dangerous Enemies,” June 8, 2010
- “We Said That? Navigating the Risks of a Robust Advertising, eMarketing & Promotions Program for Medical Products,” May 2010
- “Best Practices for Managing Deposition Expenses and Achieving Predictable Legal Costs,” December 2009
- “Product Liability and Food Contamination Seminar,” August 2002
- “The Admissibility of Medical Device Reports in Civil Litigation, Medical Device and Diagnostic Industry,” January 2001
- “Common Sense Reform or Legislative Excess?” A Survey of Recent State Tort Reform Legislation, International Legal Strategy, Vol. IX-2, February 15, 2000